Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Our Bureau

Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) today announced the launch of UDENYCA ONBODY™, the company’s on-body injector (OBI) presentation of UDENYCA® (pegfilgrastim-cbqv), is successfully underway, with a broad distribution of accounts nationwide ordering this innovative device, and patients now accessing its benefits. UDENYCA is a pegfilgrastim biosimilar administered the day after chemotherapy […]

MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment

Our Bureau

MediThinQ, a pioneering Korean startup specialising in extended reality (XR) wearable displays for surgery, is making waves as the first Asian startup to globally launch XR surgical displays. The company has successfully secured significant deals with industry giants, including Medtronic USA and Japan, marking a substantial milestone in its international expansion efforts. In […]

Medicom Recognized as One of the Most Promising Health IT Imaging Vendors of 2024 by KLAS Research

Our Bureau

Medicom Technologies, Inc. (Medicom) proudly announces its recognition as one of the most promising IT vendors in Imaging in the Emerging HCIT Companies 2024 KLAS Research report. In a recent report released on January 16th, 2024, KLAS Research showcased Medicom alongside other healthcare IT vendors across various market segments. KLAS Research conducts annual interviews with healthcare […]

New Guidance Published in The Lancet Recommends Early Intervention and Use of BIS to Reduce Impact of Arm Lymphedema on Breast Cancer Patients

Our Bureau

ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against breast cancer-related lymphedema, a common but often overlooked condition affecting breast cancer survivors. Leading medical journal eClinicalMedicine, part of The Lancet Discovery Science, recently published new clinical guidance advocating for early detection and prevention strategies, […]

FDA Advisory Committee Votes in Favor of Abbott’s First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart Valve

Our Bureau

Abbott (NYSE: ABT) today announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee for the U.S. Food and Drug Administration (FDA) confirmed 13 to 1, with 0 abstention that the benefits of Abbott’s TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people […]

New Vision-Training Software Improves Low Vision

Our Bureau

Marking the Low Vision awareness month of February, RevitalVision announced the expansion of their team in India as part of their commitment to make their US FDA-cleared vision-training software program available to maximum eye specialists in India to support their patients in improving their vision. RevitalVision is a unique perceptual-learning […]

Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers

Our Bureau

Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies’ laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers. The technique is amplification and bisulfite conversion free, effectively bypassing the most common limitations of targeted methylation analysis and enabling WBL to […]

Persistent Launches Population Health Management Solution Using Microsoft Azure OpenAI Service

Our Bureau

Persistent Systems (BSE: PERSISTENT) and (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today launched an innovative Generative AI-powered Population Health Management (PHM) Solution in collaboration with Microsoft. Aligned with value-based care models, the Solution identifies Social Determinants of Health (SDoH) to determine patients’ non-clinical needs and better predict the cost […]

INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR

Our Bureau

Insightec, a pioneer and global leader in focused ultrasound, has welcomed a positive recommendation report[1] from the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) to have MR-guided focused ultrasound (MRgFUS) reimbursed for people suffering from essential tremor (ET). This recommendation is a pivotal moment, paving the way for nation-wide access to focused […]

A.D.A.M. and the Icahn School of Medicine at Mount Sinai Announce Collaboration to Advance Bone Implant Technology and Healthcare Innovation

Our Bureau

Advanced Development of Additive Manufacturing (A.D.A.M.), a provider of 3D printing systems for customized bone implants, and the Icahn School of Medicine at Mount Sinai, in New York, NY, a renowned educational and health institution, have established a collaboration, which aims to enhance healthcare by innovating in bone implant delivery and soft tissue […]

Subscribe Now